Table 2 The adverse effects of kidney transplants recipients and healthy participants after first and second dose of inactivated vaccine.
|  | HPs (n = 52) | KTRs (n = 43) | p-value |
|---|---|---|---|
Inactivated vaccine brand of the first dose | |||
 Sinopharm BIBP (%) | 21 (40.4) | 16 (37.2) | 0.752 |
 CoronaVac (%) | 31 (59.6) | 27 (62.8) |  |
Inactivated Vaccine brand of the second dose* | |||
 Sinopharm BIBP (%) | 5 (9.6) | 16 (37.2) | 0.001 |
 CoronaVac (%) | 47 (90.4) | 27 (62.8) |  |
 Time interval between first dose and second dose (day)* | 26.69 ± 9.02 | 26.56 ± 8.15 | 0.940 |
Adverse effects after first dose | |||
 No abnormalities (%) | 32 (61.5) | 27 (62.8) | 0.844 |
 Pain at injection site (%) | 11 (21.1) | 11 (25.6) | |
 Fatigue (%) | 7 (13.5) | 4 (9.3) | |
 Dizzy (%) | 1 (1.9) | 1 (2.3) | |
 Allergy (%) | 1 (1.9) | 0 (0.0) | |
Adverse effects after second dose* | |||
 No abnormalities (%) | 37 (71.2) | 28 (67.4) | 0.569 |
 Pain at injection site (%) | 10 (19.2) | 7 (16.3) | |
 Fatigue (%) | 4 (7.7) | 5 (11.6) | |
 Dizziness (%) | 0 (0.0) | 1 (2.3) | |
 Diarrhea (%) | 0 (0.0) | 1 (2.3) | |
 Runny nose (%) | 1 (1.9) | 0 (0.0) | |
